Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Name: Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma
Published: 2020
License: Public Domain

City of Hope Medical Center · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

metastatic leiomyosarcoma, metastatic soft tissue sarcoma, stage iii uterine corpus leiomyosarcoma ajcc v8, stage iiia uterine corpus leiomyosarcoma ajcc v8, stage iiib uterine corpus leiomyosarcoma ajcc v8, stage iiic uterine corpus leiomyosarcoma ajcc v8, stage iv uterine corpus leiomyosarcoma ajcc v8, stage iva uterine corpus leiomyosarcoma ajcc v8, stage ivb uterine corpus leiomyosarcoma ajcc v8, unresectable leiomyosarcoma, unresectable soft tissue sarcoma, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Related documents